Advances and challenges in cancer immunoprevention and immune interception by Leisha A Emens, Sasha E Stanton, Philip E Castle, Shizuko Sei, Olivera J Finn

Get full text

SITC perspective: leveraging patient enrichment biomarkers to accelerate early phase IO drug development by James L Gulley, Leisha A Emens, Patrick Hwu, Carlo B Bifulco, Pamela S Ohashi, Christine Moussion, David Feltquate

Get full text

A SITC vision: adapting clinical trials to accelerate drug development in cancer immunotherapy by Pedro J Romero, Leisha A Emens, Elizabeth Garrett-Mayer, Valsamo Anagnostou, Jason J Luke, Ann W Silk, Thomas U Marron, Jane Perlmutter, Brianna Hoffner, Connie Szczepanek

Get full text

Development of [F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide by Wojciech G. Lesniak PhD, Ronnie C. Mease PhD, Samit Chatterjee PhD, Dhiraj Kumar PhD, Ala Lisok MA, Bryan Wharram MS, Venkateswara Rao Kalagadda PhD, Leisha A. Emens MD, PhD, Martin G. Pomper MD, PhD, Sridhar Nimmagadda PhD

Get full text

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer by Anne Mills, Leisha A Emens, Mary L Disis, Kunle Odunsi, John B Liao, Tyler Curiel, Margaret Gatti-Mays, Amir Jazaeri, Emese Zsiros, Marcus O Butler, Jyoti Bajpai, Katherine C Kurnit, Haider Mahdi, Laura Doherty, Claire F Friedman, Melissa A Geller, Sarah F Adams, Shelley A Dodt, Veena S John

Get full text

Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS) by Romualdo Barroso-Sousa, Jorge Gomez Tejeda Zanudo, Tianyu Li, Sangeetha M. Reddy, Leisha A. Emens, Thomas M. Kuntz, Carolina Alves Costa Silva, Saud H. AlDubayan, Hoyin Chu, Beth Overmoyer, Paulina Lange, Molly K. DiLullo, Meagan Montesion, Julie Kasparian, Melissa E. Hughes, Victoria Attaya, Ameer Basta, Nancy U. Lin, Nabihah Tayob, Rinath Jeselsohn, Elizabeth A. Mittendorf, Sara M. Tolaney

Get full text